Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Xperi Affirms FY2025 Sales Guidance of $480.00M-$500.00M vs $487.57M Est

Author: Benzinga Newsdesk | May 07, 2025 04:18pm
Xperi (NYSE:XPER) affirms FY2025 sales outlook from $480.00 million-$500.00 million to $480.00 million-$500.00 million vs $487.57 million estimate.

Posted In: XPER

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist